July 10, 2019 / 3:44 PM / 3 months ago

BRIEF-Newron: Zambon And Valeo Pharma Launch Onstryv For Parkinson's disease In Canada

July 10 (Reuters) - Newron Pharmaceuticals SpA:

* DGAP-NEWS: NEWRON’S COMMERCIALIZATION PARTNER ZAMBON AND VALEO PHARMA ANNOUNCE THE LAUNCH OF ONSTRYV(R) (SAFINAMIDE) FOR PARKINSON’S DISEASE IN CANADA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below